About this trial
The aim of this cross-over, randomized study is to assess the efficacy and pressure maintenance of MOBIDERM Autofit versus bandages in the management of Breast Cancer Related Lymphedema (BCRL) in night-time maintenance phase.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Unilateral upper limb lymphedema of stage I, II or III according to the criteria defined by the International Society of Lymphology, following breast cancer
Patient in maintenance phase of lymphedema treatment
Affected arm that fits with one of the standard sizes of the Auto- Adjustable MOBIDERM Autofit provided.
Disqualifiers
Active cellulitis / Infectious dermo-hypodermatitis
Lymphedema associated with active cancer needing acute chemotherapy
Motor and sensitive neurological deficiency / psychiatric or addictive disorders
Patients for whom compression is contraindicated, such as untreated infections, skin irritation, thrombosis: presence of skin lesions on the sleeve placement
Trial design
Treatments tested in this trial
- MOBIDERM Autofit Armsleeve
- Self-bandages